Umbralisib R-enantiomer is the R-isomer of Umbralisib (TGR-1202; RP-5264; TGR1202; RP5264; Ukoniq), which is a PI3Kδ inhibitor with antineoplastic activity and was approved as an anticancer medication in 2021.

纯度：≥98%

CAS：1532533-69-9